- Home
- CRDF vs JUNS Comparison
CRDF vs JUNS Comparison
Compare CRDF & JUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- JUNS
- Stock Information
- Founded
- CRDF 1999
- JUNS 2015
- Country
- CRDF United States
- JUNS United States
- Employees
- CRDF N/A
- JUNS N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- JUNS
- Sector
- CRDF Health Care
- JUNS
- Exchange
- CRDF Nasdaq
- JUNS NYSE
- Market Cap
- CRDF 196.2M
- JUNS 17.6M
- IPO Year
- CRDF N/A
- JUNS 2024
- Fundamental
- Price
- CRDF $2.63
- JUNS $0.62
- Analyst Decision
- CRDF Strong Buy
- JUNS
- Analyst Count
- CRDF 4
- JUNS 0
- Target Price
- CRDF $12.00
- JUNS N/A
- AVG Volume (30 Days)
- CRDF 1.1M
- JUNS 103.2K
- Earning Date
- CRDF 05-20-2025
- JUNS 05-20-2025
- Dividend Yield
- CRDF N/A
- JUNS N/A
- EPS Growth
- CRDF N/A
- JUNS N/A
- EPS
- CRDF N/A
- JUNS N/A
- Revenue
- CRDF $683,000.00
- JUNS N/A
- Revenue This Year
- CRDF N/A
- JUNS N/A
- Revenue Next Year
- CRDF N/A
- JUNS N/A
- P/E Ratio
- CRDF N/A
- JUNS N/A
- Revenue Growth
- CRDF 39.96
- JUNS N/A
- 52 Week Low
- CRDF $2.01
- JUNS $0.51
- 52 Week High
- CRDF $5.64
- JUNS $19.51
- Technical
- Relative Strength Index (RSI)
- CRDF 41.22
- JUNS N/A
- Support Level
- CRDF $2.42
- JUNS N/A
- Resistance Level
- CRDF $2.87
- JUNS N/A
- Average True Range (ATR)
- CRDF 0.18
- JUNS 0.00
- MACD
- CRDF 0.01
- JUNS 0.00
- Stochastic Oscillator
- CRDF 24.42
- JUNS 0.00
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About JUNS JUPITER NEUROSCIENCES INC
Jupiter Neurosciences Inc is a clinical-stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a resveratrol platform product that targets the treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to the majority of central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.